Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

Novel cancer treatments targeting the oncofetal factor ROR1

Reference number
Coordinator Kancera AB
Funding from Vinnova SEK 50 000
Project duration February 2014 - March 2014
Status Completed

Last updated 25 November 2019

Reference number 2014-01085

Page statistics